Table 1.
Organ and tissue weights at Day 11 and the end of study
Organ weight (mg) | Sham (n = 10) | Placebo Day 11 (n = 11) | Febuxostat Day 11 (n = 7) | Placebo final (n = 45) | Febuxostat final (n = 16) |
---|---|---|---|---|---|
Heart | 893 ± 41** | 636 ± 17 | 543 ± 15 | 553 ± 15 | 587 ± 29 |
Liver | 11 292 ± 511** | 7 480 ± 232 | 6 775 ± 359 | 5 640 ± 151 | 6 378 ± 675 |
Spleen | 632 ± 32** | 278 ± 29 | 302 ± 39 | 159 ± 8* | 253 ± 44*** |
Kidney left | 1 036 ± 26** | 728 ± 18 | 692 ± 37 | 705 ± 18 | 752 ± 36 |
White adipose tissue | 1 282 ± 173** | 203 ± 85 | 136 ± 70 | 48 ± 28 | 501 ± 221*** |
Brown adipose tissue | 311 ± 43** | 100 ± 19 | 116 ± 15 | 95 ± 5 | 139 ± 16 |
Musculus gastrocnemius | 1 426 ± 27** | 953 ± 30 | 874 ± 51 | 795 ± 20 | 911 ± 83 |
Musculus tibialis | 501 ± 7** | 315 ± 14 | 318 ± 19 | 280 ± 7 | 312 ± 32 |
Musculus extensor digitalis longus | 115 ± 6** | 80 ± 4 | 77 ± 4 | 68 ± 1 | 83 ± 8*** |
Musculus soleus | 121 ± 6* | 91 ± 4 | 85 ± 5 | 76 ± 2 | 91 ± 7*** |
P < 0.01 vs. placebo Day 11;
P < 0.001 vs. placebo Day 11;
P < 0.05 vs. placebo final.